Under construction – not a live service

Skip to content

Frontlight Research

Institution

Ankara Bilkent City Hospital

Ankara, TürkiyeWebsite

Also known as: Ankara Bilkent Şehir Hastanesi · Анкарская Городская Больница · مستشفى محافظة انقرة · AŞH

138running trials
59closed trials

Running trials

Not yet recruiting
Safety of Intraosseous Anaesthesia in Children With Haemophilia
NCT07916467· Ankara Yildirim Beyazıt University· Source
Not yet recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
NCT07900633· Phase 3· Eli Lilly and Company· Source
Not yet recruiting
A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
NCT07931547· Phase 3· Novo Nordisk A/S· Source
Recruiting
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
NCT07830732· Phase 3· Novo Nordisk A/S· Source
Not yet recruiting
Combined Metabolic Activator Supplementation in Subjects Diagnosed With Gout
NCT07889284· Phase 3· ScandiBio Therapeutics AB· Source
Recruiting
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
NCT07811193· Phase 2· Vividion Therapeutics, Inc.· Source
Recruiting
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
NCT07623161· Phase 3· Takeda· Source
Recruiting
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
NCT07623200· Phase 3· Incyte Corporation· Source
Recruiting
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
NCT07554339· Phase 3· Merck Sharp & Dohme LLC· Source
Recruiting
dPmax for Predicting Right Ventricular Failure After Left Ventricular Assist Device Implantation
NCT07918690· Pınar Kırdemir· Source
Recruiting
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
NCT07192952· Phase 3· Bayer· Source
Recruiting
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
NCT07413939· Phase 2/3· Hoffmann-La Roche· Source
Recruiting
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
NCT07513376· Phase 3· Merck Sharp & Dohme LLC· Source
Not yet recruiting
Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotension in Preeclamptic Parturients
NCT07496788· Ankara City Hospital Bilkent· Source
Recruiting
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
NCT07472517· Phase 3· Boehringer Ingelheim· Source
Recruiting
Drawing and Writing Activities in Adolescents With Type 1 Diabetes
NCT07830082· Gazi University· Source
Recruiting
Effect of Upper Extremity Support on Spatiotemporal Parameters of Gait in Individuals With Stroke
NCT07496853· Ankara Yildirim Beyazıt University· Source
Recruiting
MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
NCT07431827· Phase 3· Merck Sharp & Dohme LLC· Source
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
NCT07438496· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
NCT07227025· Phase 1/2· Janssen Research & Development, LLC· Source
Recruiting
Effects of Intensive Virtual Reality-Based Balance and Gait Training on Activity Performance and Quality of Life in Subacute Stroke Patients
NCT07431151· Ankara Yildirim Beyazıt University· Source
Active, not recruiting
Impact of GON PRF on Central Sensitization in Migraine Patients
NCT07343427· Ankara City Hospital Bilkent· Source
Recruiting
PENG Block & PENG PRF
NCT07360093· Ankara City Hospital Bilkent· Source
Recruiting
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
NCT07195695· Phase 3· Boehringer Ingelheim· Source
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566· Phase 3· Pfizer· Source
Recruiting
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
NCT07221474· Phase 2· Merck Sharp & Dohme LLC· Source
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380· Phase 3· Eli Lilly and Company· Source
Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
NCT07218146· Phase 3· Zai Lab (Shanghai) Co., Ltd.· Source
Recruiting
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
NCT07188805· Phase 3· Bayer· Source
Active, not recruiting
Comparison of Peak Expiratory Flow Changes After Robot-Assisted Versus Open Radical Prostatectomy
NCT07262073· Ankara City Hospital Bilkent· Source
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
NCT07165028· Phase 3· Eli Lilly and Company· Source
Recruiting
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
NCT07190248· Phase 3· Merck Sharp & Dohme LLC· Source
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
NCT07196722· Phase 2/3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
NCT07196748· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
NCT07028853· Phase 3· Pfizer· Source
Active, not recruiting
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
NCT07160335· Phase 1· Shanghai Henlius Biotech· Source
Recruiting
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
NCT07037758· Phase 1· Amgen· Source
Recruiting
TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%
NCT07279402· Antalya Training and Research Hospital· Source
Recruiting
Evaluation of Perioperative Myocardial Injury in Patients Undergoing Below-Knee Lower Extremity Surgery
NCT07241572· Ankara City Hospital Bilkent· Source
Active, not recruiting
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
NCT07005128· Phase 3· Amgen· Source
Recruiting
Effects of Sacral and Tibial Stimulation on Bladder Function in Subacute Suprasacral Spinal Cord Injury
NCT07343583· Ankara City Hospital Bilkent· Source
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
NCT07062965· Phase 3· Pfizer· Source
Recruiting
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
NCT06780111· Phase 1/2· Merck Sharp & Dohme LLC· Source
Active, not recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433· Phase 3· Amgen· Source
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401· Phase 3· Pfizer· Source
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473· Phase 3· Boehringer Ingelheim· Source
Recruiting
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
NCT06863272· Phase 1/2· Merck Sharp & Dohme LLC· Source
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700· Phase 3· Merck Sharp & Dohme LLC· Source
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459· Phase 3· Amgen· Source
Recruiting
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
NCT06787612· Phase 2· Regeneron Pharmaceuticals· Source

Showing 50 of 138.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Closed trials

Completed
Serum Betatrophin Levels in Normal-Weight and Overweight Adolescents With PCOS
NCT07480993· Ankara City Hospital Bilkent· Source
Completed
The Condition of the Temporomandibular Joint in Hemiplegia
NCT07698184· Ayşe Ukbe Baykut· Source
Completed
Evaluation of the Effects of Anti-TNF Therapy on the Retina in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis
NCT07931352· Ankara City Hospital Bilkent· Source
Completed
Evaluation of Interoception, Fatigue, and Upper and Lower Extremity Functional Capacity in Multiple Sclerosis Patients With Good and Poor Sleep Quality
NCT07374237· Gulhane School of Medicine· Source
Completed
Comparison of Fentanyl and Magnesium to Control Reflex Hemodynamics in Patients Aged 50 and Older
NCT07258628· Ankara City Hospital Bilkent· Source
Completed
Comparative Effectiveness of Genicular Nerve Radiofrequency Thermocoagulation and Intra-Articular Pulsed Radiofrequency in the Management of Knee Osteoarthritis Pain
NCT07098455· Ankara City Hospital Bilkent· Source
Completed
Predictive Value of Witness-derived Secondary Cincinnati Prehospital Stroke Scale Scores in Suspected Stroke
NCT07277790· Ankara City Hospital Bilkent· Source
Completed
The Effects of Augmented Reality Versus Virtual Reality
NCT07113093· Ankara Yildirim Beyazıt University· Source
Completed
Gait Characteristics at Different Speeds in Individuals With Stroke
NCT07114575· Ankara Yildirim Beyazıt University· Source
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
NCT07060807· Phase 3· Merck Sharp & Dohme LLC· Source
Completed
Comparison of Propofol and Propofol-Ketamine Anesthesia on Optic Nerve Sheath Diameter in Endovascular Cerebral Aneurysm Procedures
NCT07542015· Ankara City Hospital Bilkent· Source
Completed
Endometriosis-Angiopoietin-like Protein-4
NCT07164196· Ankara City Hospital Bilkent· Source
Completed
Impact of rTMS Combined With Neurorehabilitation on Lower Extremity Motor Function and Spasticity in Children With Spastic Diplegic Cerebral Palsy
NCT07488429· Ankara City Hospital Bilkent· Source
Completed
Effect of Hemovac Drain Removal on Early Outcomes After Total Knee Arthroplasty
NCT07342894· Ankara City Hospital Bilkent· Source
Completed
Comparison of the Effects of Robotic Rehabilitation, Functional Electrical Stimulation and Occupational Therapy on Upper Extremity and Hand Functions in Tetraplegic Patients With Spinal Cord Injury
NCT06912217· Ankara City Hospital Bilkent· Source
Completed
Sphenopalatine Ganglion Pulsed Radiofrequency Treatment Outcomes
NCT07370142· Ankara City Hospital Bilkent· Source
Completed
Biopsy Needle Size in Soft Tissue Sarcoma
NCT07066774· Ankara City Hospital Bilkent· Source
Completed
The Effect of Pulsed Radiofrequency Ablation of the Genicular Nerve on Pain, Balance, and Proprioception in Patients With Chronic Knee Osteoarthritis
NCT07869771· Ankara City Hospital Bilkent· Source
Completed
The Effect of Immersive Virtual Reality and Relaxing Videos on Lung Cancer Patients
NCT06863623· Hacettepe University· Source
Recruiting
The Effects of Functional Electrical Stimulation (FES) and Exercise on the Quadriceps in Patients With Knee Osteoarthritis
NCT07309003· Ankara City Hospital Bilkent· Source
Completed
Fluid Responsiveness Through the Corrected Carotid Flow Time, Before and After Sternotomy
NCT06967142· Ankara City Hospital Bilkent· Source
Completed
Comparing Unilateral and Bilateral Proximal GONPRF in Migraine Treatment
NCT06894121· Ankara City Hospital Bilkent· Source
Completed
Effect of Genicular Nerve Block on Proprioception in Knee Osteoarthritis
NCT06744842· Ankara City Hospital Bilkent· Source
Completed
Iron Accumulation in Erythrocytes in Patients
NCT07486531· Ankara City Hospital Bilkent· Source
Completed
The Use of Virtual Reality and Music Therapy for Hypertensive Urgency
NCT07272486· Ankara City Hospital Bilkent· Source
Recruiting
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
NCT06559306· Phase 3· Janssen Research & Development, LLC· Source
Completed
A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer
NCT06532032· Phase 1/2· Janssen Research & Development, LLC· Source
Completed
THE EFFECTS OF FUNCTIONAL ELECTRICAL STIMULATION-ASSISTED BICYCLE ERGOMETRY IN PATIENTS DIAGNOSED WITH COMPLEX REGIONAL PAIN SYNDROME.(CRPS)
NCT07570199· Zeynep Nur Köseoğlu· Source
Completed
Effect of Preoperative Cold Therapy on Early Postoperative Outcomes in Total Knee Arthroplasty
NCT07134283· Ankara City Hospital Bilkent· Source
Completed
Effects of Ultrasound-guided Genicular Nerve Block in Knee Osteoarthritis Patients on Proprioception and Static Balance
NCT06527651· Ankara City Hospital Bilkent· Source
Completed
The Effect of Acupuncture on Sarcopenia and Obesity in Patients With Sarcopenic Obesity.
NCT07797140· Ayşe Ukbe Baykut· Source
Completed
Comparison of Airway Management With Bronchial Blocker and Double-Lumen Tube in Single-Lung Ventilation
NCT06299735· Ankara City Hospital Bilkent· Source
Completed
Comparison of Music and Ambient Noise Cancellation in Patients Undergoing Total Knee Arthroplasty (TKA)
NCT06401018· Ankara City Hospital Bilkent· Source
Completed
Stellate Ganglion Blockade for Refractory Chronic Migraine
NCT06891118· Ankara City Hospital Bilkent· Source
Completed
The Effect of Change Stage-Based Physical Activity Counseling on Physically Inactive Individuals With Hypertension
NCT07068100· Ankara City Hospital Bilkent· Source
Completed
Correlation of Ultrasound-Measured Detrusor and Bladder Wall Thickness With Urodynamic Parameters in Spinal Cord Injury
NCT07419165· Ankara City Hospital Bilkent· Source
Completed
Autism Traits in Adolescents With Social Anxiety Disorder: Associations With Parental Broader Autism Phenotype
NCT07106840· Ankara City Hospital Bilkent· Source
Completed
Anesthesia Management of Coronary Artery Bypass Surgery and Inflammatory Biomarkers
NCT06209437· Ankara City Hospital Bilkent· Source
Completed
Evaluation of Oxygen Reserve Index (ORi) in Obese and Non-Obese Patients Over 65 Years Old
NCT07679724· Ankara City Hospital Bilkent· Source
Completed
Comparison of Infraclavicular Brachial Plexus Block and Local Anesthesia in Arteriovenous Fistula Surgeries and Their Effects on Tissue Oxygen Saturation
NCT06416111· Ankara City Hospital Bilkent· Source
Completed
Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)
NCT06036836· Phase 2· Merck Sharp & Dohme LLC· Source
Completed
Gluteal Sling Release on Gluteal Dysfunction After in Primary Total Hip Arthroplasty
NCT06850155· Ankara City Hospital Bilkent· Source
Completed
Electromyography-Triggered Electrical Stimulation on Trunk Balance and Muscle Thickness in SCI Patients
NCT06527417· Ankara City Hospital Bilkent· Source
Completed
The Effect Of High Intensity Interval Training And Moderate Intensity Continuous Training In Patients With Hypertension
NCT06243224· Ankara City Hospital Bilkent· Source
Completed
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT05811351· Phase 2· Janssen Research & Development, LLC· Source
Completed
A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)
NCT05724199· Phase 3· Amgen· Source
Completed
A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
NCT05564052· Phase 2· Janssen Research & Development, LLC· Source
Completed
Cardiac Rehabilitation in Heart Failure and Sarcopenia
NCT07245459· Ankara City Hospital Bilkent· Source
Completed
Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
NCT05052801· Phase 3· Amgen· Source
Completed
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
NCT04936308· Phase 3· Janssen Research & Development, LLC· Source

Showing 50 of 59.

Registry name variants (46)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Ankara Bilkent City Hospital
Ankara, 6800
88 trials
Ankara Bilkent Sehir Hastanesi
Ankara, 06800
51 trials
Ankara Bilkent City Hospital
Çankaya, Ankara 06800
3 trials
- NCT07623161A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
  Contact: Marve Pamukcuoglu (principal investigator)
- NCT06967142Fluid Responsiveness Through the Corrected Carotid Flow Time, Before and After Sternotomy
- NCT03301506Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)
Ankara Bilkent Sehir Hastanesi
Bilkent Ankara, Aksaray 6800
3 trials
- NCT07192952A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- NCT07188805A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- NCT06452277A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Ankara Bilkent Sehir Hastanesi
Çankaya, 06800
3 trials
- NCT07227025A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
- NCT06532032A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer
- NCT05488314A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer
Ankara Bilkent Şehir Hastanesi. (Site 0142)
Ankara, 06800
3 trials
- NCT06780098Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
  Contact: Study Coordinator
- NCT06780085A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
- NCT06731907A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
  Contact: Study Coordinator
Ankara city hospital bilkent
Ankara, Çankaya 06800
3 trials
- NCT07542015Comparison of Propofol and Propofol-Ketamine Anesthesia on Optic Nerve Sheath Diameter in Endovascular Cerebral Aneurysm Procedures
- NCT06401018Comparison of Music and Ambient Noise Cancellation in Patients Undergoing Total Knee Arthroplasty (TKA)
- NCT06209437Anesthesia Management of Coronary Artery Bypass Surgery and Inflammatory Biomarkers
Ankara Bilkent Sehir Hastanesi
Türkiye
2 trials
- NCT07472517DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
  Contact: Boehringer Ingelheim
- NCT07195695Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
  Contact: Boehringer Ingelheim
Ankara Bilkent Sehir Hastanesi (Site 2002)
Ankara, 06800
2 trials
- NCT06623422A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
  Contact: Study Coordinator
- NCT04380636Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
Ankara Bilkent Sehir Hastanesi (Site 2105)
Ankara, 06800
2 trials
- NCT07060807A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
  Contact: Toll Free Number
- NCT03976323Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)
Ankara Bilkent Şehir Hastanesi (Site 2500)
Ankara, 06800
2 trials
- NCT06305754Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
- NCT06170788Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
  Contact: Study Coordinator
Health Sciences University, Ankara Bilkent City Hospital
Ankara, Cankaya 06800
2 trials
- NCT06894121Comparing Unilateral and Bilateral Proximal GONPRF in Migraine Treatment
- NCT06891118Stellate Ganglion Blockade for Refractory Chronic Migraine
7920016 - Ankara Sehir Hastanesi Bilkent
Çankaya, 06800
1 trial
- NCT03473223Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
Ankara Bilkent City Hospital, Ankara, Türkiye
Ankara
1 trial
- NCT07258706Demographic and Interpopulation Variations in Evaluation and Results of TAVI
Ankara Bilkent City Hospital, Department of Anesthesiology
Ankara, Çankaya
1 trial
- NCT07262073Comparison of Peak Expiratory Flow Changes After Robot-Assisted Versus Open Radical Prostatectomy
Ankara Bilkent City Hospital, Department of Anesthesiology and Reanimation
Ankara, Ankara 06800
1 trial
- NCT07258628Comparison of Fentanyl and Magnesium to Control Reflex Hemodynamics in Patients Aged 50 and Older
Ankara Bilkent City Hospital Department of Medical Oncology
Ankara, 6800
1 trial
- NCT07160335A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
Ankara Bilkent City Hospital, Oncology Department
Çankaya, 6800
1 trial
- NCT06112314IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Ankara Bilkent City Hospital (Site 2403)
Ankara, 06800
1 trial
- NCT05224141Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)
Ankara Bilkent Sehir Hastanesi
Ankara Sehir Hastanesi, 06800
1 trial
- NCT05564052A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
Ankara Bilkent Sehir Hastanesi
Bilkent Çankaya, Ankara 6800
1 trial
- NCT07811193A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Ankara Bilkent Sehir Hastanesi - 2610
Ankara, 06800
1 trial
- NCT05671510ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Ankara Bilkent Şehir Hastanesi (Site 0427)
Ankara, 06800
1 trial
- NCT06036836Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)
Ankara Bilkent Şehir Hastanesi (Site 0654)
Ankara, 06800
1 trial
- NCT06863272A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
  Contact: Study Coordinator
Ankara Bilkent Şehir Hastanesi. (Site 0904)
Ankara, 06800
1 trial
- NCT04924075Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
  Contact: Study Coordinator
Ankara Bilkent Şehir Hastanesi (Site 1402)
Ankara, 06800
1 trial
- NCT07221474A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
  Contact: Study Coordinator
Ankara Bilkent Şehir Hastanesi. (Site 1403)
Ankara, 06800
1 trial
- NCT05587712Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
  Contact: Study Coordinator
Ankara Bilkent Şehir Hastanesi (Site 1801)
Ankara, 06800
1 trial
- NCT06353386Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
Ankara Bilkent Şehir Hastanesi (Site 1811)
Ankara, 06800
1 trial
- NCT07431827MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
  Contact: Study Coordinator
Ankara Bilkent Şehir Hastanesi. (Site 1906)
Çankaya, Ankara 6800
1 trial
- NCT07554339A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
  Contact: Study Coordinator
Ankara Bilkent Şehir Hastanesi (Site 1962)
Ankara, 06800
1 trial
- NCT06395103Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
  Contact: Study Coordinator
Ankara Bilkent Sehir Hastanesi (Site 2007)
Ankara, 06800
1 trial
- NCT04624204Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
Ankara Bilkent Şehir Hastanesi (Site 2100)
Ankara, 06800
1 trial
- NCT06345729A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
  Contact: Study Coordinator
Ankara Bilkent Şehir Hastanesi. (Site 2307)
Ankara, 06800
1 trial
- NCT05612035Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD
Ankara Bilkent Sehir Hastanesi (Site 2401)
Ankara, 06800
1 trial
- NCT07190248A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
  Contact: Study Coordinator
Ankara Bilkent Sehir Hastanesi (Site 2503)
Ankara, 06800
1 trial
- NCT06698042A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
Ankara Bilkent Şehir Hastanesi (Site 3201)
Ankara, 06800
1 trial
- NCT06079879A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
Ankara Bilkent Şehir Hastanesi. (Site 3300)
Ankara, 06800
1 trial
- NCT05714085Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
  Contact: Study Coordinator
Ankara Bilkent Sehir Hastanesi (Site 3412)
Ankara, 06800
1 trial
- NCT06780137A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
  Contact: Study Coordinator
Ankara Bilkent Şehir Hastanesi. (Site 3962)
Ankara, 6800
1 trial
- NCT06941272A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
  Contact: Study Coordinator
Ankara Bilkent Sehir Hastanesi (Site 4306)
Ankara, 6800
1 trial
- NCT07513376A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
  Contact: Study Coordinator
Ankara Bilkent Şehir Hastanesi (Site 4801)
Ankara, 06800
1 trial
- NCT06841354A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
  Contact: Study Coordinator
Ankara Bilkent Şehir Hastanesi. (Site 5114)
Ankara, 06800
1 trial
- NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
  Contact: Study Coordinator
Ankara Bilkent Şehir Hastanesi (Site 9403)
Ankara, 06800
1 trial
- NCT06780111Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
  Contact: Study Coordinator
Ankara City Hospital Bilkent, Ankara, Ankara 06800
Ankara, 06050
1 trial
- NCT06941038Intraoperative vs. Postoperative Intravesical Epirubicin Instillation for Prevention of Bladder Recurrence in High-Risk Upper Urinary Tract Urothelial Carcinoma
Ankara Yıldırım Beyazıt University, Faculty of Medicine, Ankara Bilkent City Hospital, Department of Emergency Medicine
Çankaya, Ankara 06800
1 trial
- NCT07277790Predictive Value of Witness-derived Secondary Cincinnati Prehospital Stroke Scale Scores in Suspected Stroke

Conditions

Diseases this institution publishes on or runs trials for.

Institution data: ROR 033fqnp11 (CC0-1.0)Updated 12 Nov 2026

Report an error

Under construction, not live – Ankara Bilkent City Hospital: trials and research groups – Frontlight Research